Virax Biolabs Group Ltd (VRAX)

[Muhbruh]

$VRAX penny bio with just 2.8m marketcap and 3m float & 0.89 cash per share with 9% short interest and only 50k borrows on IBKR

- Virax plans to hold a pre-submission meeting with the FDA in early September 2025.

Virax Biolabs is preparing for a pre-submission meeting with the FDA to discuss the regulatory pathway for ViraxImmune™.

- last offering was at 4.50 & the lowest warrants are at 2.93 with customary anti-dilution price protection so can't adjust exercise price lower

- has until January 12, 2026 for 1.00 compliance so plenty of time